Both in Management Consulting
GENPACT LIMITED vs Astrana Health
Over the past year G returned +5.9% and ASTH returned +17.4%; their daily moves had a correlation of -0.08.
G +5.9% ASTH +17.4%Growth of $1, one year, split-adjusted
| Metric | G | ASTH |
|---|---|---|
| Price | $41.10 | $39.01 |
| Market cap | $6.87B | $1.94B |
| Today | +0.78% | −1.66% |
| 1 month | +22.1% | +5.0% |
| 6 months | +19.2% | +8.1% |
| Year to date | −12.1% | +57.2% |
| 1 year | +6.9% | +17.9% |
| Revenue growth (YoY) | +7.1% | +48.5% |
| Gross margin | 36.5% | 10.7% |
| Net margin | 10.8% | 2.0% |
| P/E (TTM) | 11.8× | 47.7× |
| Price / sales | 1.3× | 0.5× |
| Net cash | -$662.9M | -$535.7M |
| Dividend yield | 1.82% | — |
| Volatility (60d) | 36.0% | 45.6% |
| Short % of float | 6.7% | 6.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).